St. Petersburg Research Institute of Vaccines and Sera

ACTIVE

RussiaPrivate

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 3

40.0%

Phase 1

33.3%

Phase 2

26.7%

Trial Status Distribution

Active, not recruiting

6.7%

Completed

86.7%

Recruiting

6.7%

Clinical Trials

Trials sponsored by this organization (15)

Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older

Phase 2

Active, not recruiting

interventional

Oct 202216,304 participants

Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children

Phase 3

Recruiting

interventional

Jan 2022948 participants

Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.

Phase 1

Completed

interventional

Jul 2021155 participants

Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra

Phase 2

Completed

interventional

Mar 2021633 participants

Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old

Phase 3

Completed

interventional

Feb 20211,066 participants

Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years

Phase 3

Completed

interventional

Dec 2020654 participants

Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine

Phase 2

Completed

interventional

Oct 2020450 participants

The Objectives of This Study Are Study the Immunogenicity and Safety of the Flu-M [Inactivated Split Influenza Vaccine], vs. the Ultrix® Inactivated Split Influenza Vaccine, in Volunteers Who Are Over 60 Years Old

Phase 3

Completed

interventional

Mar 2020320 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations